Literature DB >> 8616786

Chromosome telomere integrity of human solid neoplasms.

M G Butler1, M Sciadini, L K Hedges, H S Schwartz.   

Abstract

Eukaryotic chromosomes contain specialized structures at the termini called telomeres. This region of DNA is required for replication and stability of the chromosome. Telomere reduction can contribute to genetic instability and has been described in certain malignancies (e.g., colon, leukemia, giant cell tumor of bone). To determine whether telomere reduction is a generalized phenomenon in malignancies, the telomere integrity of genomic DNA isolated from tumor cells was determined from 39 individuals with 15 different malignancies categorized as musculoskeletal, epithelial, cranial, or other, and peripheral blood leukocytes from the same patient, when possible, or age-matched controls. Significant telomere reduction occurred randomly across histopathologic groups including giant cell tumor of bone, glioblastoma, colon cancer, and Wilms' tumor while telomere elongation occurred in chordoma. The other remaining 10 malignancies do not show significant differences in telomere lengths compared with controls.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616786      PMCID: PMC6002753          DOI: 10.1016/0165-4608(95)00142-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  14 in total

1.  Significant telomere shortening in childhood leukemia.

Authors:  D J Adamson; D J King; N E Haites
Journal:  Cancer Genet Cytogenet       Date:  1992-07-15

Review 2.  Giant cell tumor of bone. Chromosomal analysis of 48 specimens and review of the literature.

Authors:  J A Bridge; J R Neff; B J Mouron
Journal:  Cancer Genet Cytogenet       Date:  1992-01

3.  Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts.

Authors:  W E Wright; O M Pereira-Smith; J W Shay
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

4.  Telomeric fusions in a Wilms' tumor.

Authors:  A C Fett-Conte; H Liedtke Júnior; H Chaves; J A Thomé; E H Tajara
Journal:  Cancer Genet Cytogenet       Date:  1993-09

5.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

6.  Telomeric associations and consistent growth factor overexpression detected in giant cell tumor of bone.

Authors:  H S Schwartz; M G Butler; R B Jenkins; D A Miller; H L Moses
Journal:  Cancer Genet Cytogenet       Date:  1991-10-15

7.  Telomere length predicts replicative capacity of human fibroblasts.

Authors:  R C Allsopp; H Vaziri; C Patterson; S Goldstein; E V Younglai; A B Futcher; C W Greider; C B Harley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

8.  Telomere reduction in giant cell tumor of bone and with aging.

Authors:  H S Schwartz; G A Dahir; M G Butler
Journal:  Cancer Genet Cytogenet       Date:  1993-12

9.  Molecular analysis of transforming growth factor beta in giant cell tumor of bone.

Authors:  M G Butler; G A Dahir; H S Schwartz
Journal:  Cancer Genet Cytogenet       Date:  1993-04

10.  Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics.

Authors:  E Hiyama; K Hiyama; T Yokoyama; T Ichikawa; Y Matsuura
Journal:  Jpn J Cancer Res       Date:  1992-02
View more
  3 in total

1.  Clonality studies in sacral chordoma.

Authors:  Lance Klingler; Rita Trammell; D Gordon Allan; Merlin G Butler; Herbert S Schwartz
Journal:  Cancer Genet Cytogenet       Date:  2006-11

2.  Telomerase activity in skeletal sarcomas.

Authors:  G Aue; B Muralidhar; H S Schwartz; M G Butler
Journal:  Ann Surg Oncol       Date:  1998 Oct-Nov       Impact factor: 5.344

3.  Microsatellite instability in sarcomas.

Authors:  S S Martin; W G Hurt; L K Hedges; M G Butler; H S Schwartz
Journal:  Ann Surg Oncol       Date:  1998-06       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.